News

Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and costs, and improve overall operational efficiency

The FRED X Flow Diverter is the Next Generation in Flow Diversion Technology

MicroVention’s WEB System is the World Leader and Only PMA-Approved Intrasaccular Flow Disruptor; Advances Treatment of Wide-Neck Bifurcation Aneurysms with ONE Device

MicroVention Now Offers a Fully Integrated, Comprehensive Stroke Portfolio, Delivering Breakthrough Innovation from Access to Revascularization

Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia® Apheresis System at major conferences

52.2 Billion JPY Capital Investment to Strengthen the Production Capability to Meet the Growing Global Demands

First patient enrolled in the NAGOMI COMPLEX PMCF study

Findings show intra-vascular access via the radial artery can successfully be used as the primary strategy for the modern embolization practice

Presentation at CAR-TCR Summit Europe demonstrates scalability and reduced media usage enable lower cost to produce a dose of autologous T-cell therapy

IMUGARD to Help Strained U.S. Platelet Supply Meet Growing Need

Trial aims to assure Terumo’s Misago® RX Self-expanding Peripheral Stent is safe and effective

This addition of a new reimbursement category will allow more people the opportunity for better diabetes management

The Nation’s First Emergency Blood Reserve Aims to Help When Disaster Strikes

Researchers used Terumo Health Outcomes’ ePRISM® software to calculate safe contrast volume targets and improve overall patient outcomes